鶹ý

Feature Channels: Biotech

Filters close
鶹ý: Purple Tea Decoded: Genetic Insights Into Nature's Health Elixir
Released: 21-Nov-2024 8:15 AM EST
Purple Tea Decoded: Genetic Insights Into Nature's Health Elixir
Chinese Academy of Sciences

A cutting-edge study has unveiled the genetic mechanisms that shape the vibrant purple leaves of tea plants, renowned for their health-enhancing anthocyanins. By exploring the genetic variations and differential gene expression behind this unique coloration, the research provides key insights into the molecular control of anthocyanin biosynthesis, paving the way for innovations in tea breeding.

鶹ý: Five Journals Successfully Indexed in Emerging Sources Citation Index (ESCI) of Web of Science by Maximum Academic Press
Released: 21-Nov-2024 3:05 AM EST
Five Journals Successfully Indexed in Emerging Sources Citation Index (ESCI) of Web of Science by Maximum Academic Press
Chinese Academy of Sciences

We are thrilled to announce that five of our journals include Fruit Research, Vegetable Research, Ornamental Plant Research, Grass Research and Forestry Research have been officially indexed in the Emerging Sources Citation Index (ESCI) of Web of Science. This achievement marks a significant milestone in our ongoing efforts to elevate the global visibility and academic impact of our journals.

鶹ý: Decoding and Debugging Biological Programs for a Healthier Future
Released: 20-Nov-2024 12:10 PM EST
Decoding and Debugging Biological Programs for a Healthier Future
Sanford Burnham Prebys

Alessandro Vasciaveo, PhD, joined Sanford Burnham Prebys as an assistant professor in computational biology and artificial intelligence in fall 2024. He uses his training and experience as a scientist and engineer to advance knowledge of human biology through research, and to identify novel treatments and cures for diseases.

鶹ý: Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to Offer Joint Ph.D. Program in Health Sciences Engineering
Released: 20-Nov-2024 11:05 AM EST
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to Offer Joint Ph.D. Program in Health Sciences Engineering
Rensselaer Polytechnic Institute (RPI)

Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai will offer a joint Ph.D. program in health sciences engineering beginning in the fall semester of 2025. RPI is a world-renowned technological research university known for its engineering, technology, and science programs.

鶹ý: Iron-clad Defense: How Microbes Shield Tomato Crops From Bacterial Wilt
Released: 20-Nov-2024 8:10 AM EST
Iron-clad Defense: How Microbes Shield Tomato Crops From Bacterial Wilt
Chinese Academy of Sciences

A new study has discovered that siderophores, molecules produced by certain bacteria, are instrumental in the microbiome's defense against Ralstonia solanacearum, a pathogen causing severe crop losses. The research indicates that siderophores significantly boost the inhibitory effects of Pseudomonas strains on the pathogen, particularly under iron-limited conditions, offering a new avenue for developing eco-friendly disease control strategies in agriculture.

15-Nov-2024 8:00 AM EST
An Innovative Antibiotic for Drug-Resistant Bacteria
American Chemical Society (ACS)

Building on previous work, researchers in ACS Infectious Diseases have demonstrated a potential antibacterial treatment from a modified darobactin, a compound originally from a bacterium. The team reports proof-of-concept animal trials on infections caused by bacteria, including E. coli, that are known to develop drug resistance.

   
鶹ý: Low-Cost Phenotyping System Unveils Key Insights Into Quantitative Disease Resistance in Wild Tomatoes
Released: 19-Nov-2024 10:10 PM EST
Low-Cost Phenotyping System Unveils Key Insights Into Quantitative Disease Resistance in Wild Tomatoes
Chinese Academy of Sciences

A research team reveals how a low-cost imaging phenotyping system successfully uncovers the mechanisms of quantitative disease resistance (QDR) in wild tomato species.

鶹ý: New Research Could Pave Way for Vaccine Against Deadly Wildlife Disease
Released: 19-Nov-2024 3:35 PM EST
New Research Could Pave Way for Vaccine Against Deadly Wildlife Disease
Michigan State University

Sean Crosson, a Professor Rudolph Hugh Endowed Chair in Michigan State University’s Department of Microbiology, Genetics and Immunology, has been awarded a $2.4 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to study the cause of that very disease, Brucella abortus.

Released: 19-Nov-2024 3:15 PM EST
Solis Agrosciences Acquires Genomics Platform to Provide Genotyping and Bioinformatics Services to Agriculture Companies
Donald Danforth Plant Science Center

Solis will provide end-to-end genomics services enabling better-informed decisions, resulting in the development of more productive and resilient plants and animals

Released: 19-Nov-2024 2:30 PM EST
How Colliding Genetic Processes Drive Aggressive Cancers
University of Chicago Medical Center

Mutations in certain genes can lead to the accumulation of DNA errors, resulting in a specific type of genetic change known as large tandem duplications (TDs) that can arise from the collision of two critical cellular processes: transcription and DNA replication.

access_time Embargo lifts in 2 days
This news release is embargoed until 25-Nov-2024 3:00 PM EST Released to reporters: 19-Nov-2024 12:25 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 25-Nov-2024 3:00 PM EST The 鶹ý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Nov-2024 10:10 AM EST
4 Things to Know About Lung Cancer Screening and Treatment
American College of Surgeons (ACS)

Lung cancer is responsible for approximately 1 in 4 cancer deaths in the United States, making it the deadliest cancer among Americans. However, early detection and advancements in treatment can significantly improve patient outcomes.

Released: 18-Nov-2024 9:45 AM EST
Innovative Mayo Clinic Test May Improve Mesothelioma Detection Rate in Blood
Mayo Clinic

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood.

鶹ý: Neuro-Oncology Experts Reveal How to Use AI to Improve Brain Cancer Diagnosis, Monitoring, Treatment
Released: 14-Nov-2024 2:40 PM EST
Neuro-Oncology Experts Reveal How to Use AI to Improve Brain Cancer Diagnosis, Monitoring, Treatment
Indiana University

An international team of neuro-oncology researchers and clinicians has released new recommendations for good clinical practice regarding the use of artificial intelligence methods to more accurately diagnose, monitor and treat brain cancer.

鶹ý: The Wistar Institute’s Education and Training Center Receives $100,000 NIIMBL eXperience Grant
Released: 14-Nov-2024 2:40 PM EST
The Wistar Institute’s Education and Training Center Receives $100,000 NIIMBL eXperience Grant
Wistar Institute

The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weeklong training program at the Institute.

Released: 14-Nov-2024 1:35 PM EST
Personalized Breast Cancer Treatment through Non-Invasive Liquid Biopsy
Sbarro Health Research Organization (SHRO)

In patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer, the molecular classification of their case plays a pivotal role in the formulation of personalized treatment plans aimed at optimizing outcomes. Despite notable advancements in this field, significant challenges persist. Issues such as pre-analytical variability, interpretative ambiguity, and inconsistent threshold definitions hinder accurate diagnosis and subsequent treatment decisions. In this context, emerging liquid biopsy technologies present a promising solution.

鶹ý: 1920_stemcellsinspace.jpg?10000
Released: 14-Nov-2024 10:45 AM EST
New Stem Cell Data From Space
Cedars-Sinai

Cedars-Sinai investigators are one step closer to manufacturing stem cells in space, which could speed up the development of new medical therapies on Earth. The first published data from the experiments conducted on a private space mission appeared in the peer-reviewed Nature portfolio journal NPJ Microgravity.

鶹ý: Maryland_Stem_Cell_Research_Commission__Ruchika_Nijhara_PhD_executive_director_of_Maryland_Stem_Ce.jpg
Released: 14-Nov-2024 10:40 AM EST
Applications Now Open for 2025 Maryland Stem Cell Research Fund Grant Programs
Maryland Stem Cell Research Commission

The Maryland Stem Cell Research Commission (MSCRC) announces the release of a Request for Applications (RFA) for the Maryland Stem Cell Research Fund's (MSCRF) second funding cycle of Fiscal Year 2025 (FY25).

鶹ý: “We Need Everyone”: New Award Recognizes the Importance of Scientific Community
Released: 13-Nov-2024 1:30 PM EST
“We Need Everyone”: New Award Recognizes the Importance of Scientific Community
University of Utah Health

In the lab of Minna Roh-Johnson, PhD, great science and great mentorship are inextricable. Now, up to $250,000 in federal funding from the National Cancer Institute has made that philosophy concrete by advancing cancer research and building scientific community.

Released: 13-Nov-2024 1:15 PM EST
Un avance hacia medicamentos y vacunas inhalables de ARNm
American Chemical Society (ACS)

A la mayoría de la gente no le gusta aplicarse vacunas o inyecciones para recibir tratamientos. Por eso, los investigadores trabajan para crear más medicamentos, como los que se fabrican a partir de ARN mensajero (ARNm), que puedan pulverizarse e inhalarse. Un estudio publicado en la revista Journal of the American Chemical Society informa sobre los avances para hacer posible los medicamentos de ARNm inhalables. Los investigadores indican que la nanopartícula de polímero lipídico, que es estable cuando se nebuliza y libera aerosoles (gotitas líquidas) en los pulmones de ratones de forma satisfactoria, se optimizó para contener el ARNm.

   


close
2.63001